ClinicalTrials.Veeva

Menu

The Use of Klorsept Solution for Debriding Infected Wounds: is it Effective and Safe? Prospective Observational Study

I

Israel Healthcare Foundation

Status

Unknown

Conditions

Infected Wound
Non-healing Wound

Treatments

Device: latent available chlorine (LAC)

Study type

Observational

Funder types

Other

Identifiers

NCT03049670
Any unique identifier assigned

Details and patient eligibility

About

Klorsept is a debridement solution of necrotic infected tissue promoting wound healing. The aim of this study is to elaborate the effectiveness and safety of this solution.

Full description

Klorsept is a debridement solution of necrotic infected tissue promoting wound healing. The aim of this study is to elaborate the effectiveness and safety of this solution.

This study will include 50 patients suffering from necrotic and infected wounds. Several parameters will be evaluated in order to provide the effectiveness and safety of this treatment.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • hospitalized patients with infected wounds who can sign an informed consent

Exclusion criteria

  • patient that can not sign an informed consent
  • pregnant woman
  • age less than 18 years
  • Allergy to chlorine

Trial design

50 participants in 1 patient group

latent available chlorine (LAC)
Description:
applying LAC on infected wounds
Treatment:
Device: latent available chlorine (LAC)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems